Clinical trial of new therapy for anterior cruciate ligament reconstruction with the use of autologous injured tissue

Clinical trial of new therapy for anterior cruciate ligament reconstruction with the use of autologous injured tissue - Anterior cruciate ligament reconstruction with the use of autologous injured tissue

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007285

Enrollment

Registered

2012-02-13

Start date

2011-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior cruciate ligament injury

Interventions

anterior cruciate ligament reconstruction

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) anterior cruciate ligament injury diagnosed by physical examination and magnetic resonance image 2) injury within 3 months 3) isolated injury 4) Informed consent by writing

Exclusion criteria

Exclusion criteria: 1) Patients receiving radiation, chemotherapy, immunosuppression, or chronic steroids 2) Patients with complete neuropathy that would interfere with walking or appreciation of pain 3) 4000<WBC<10000 4) Patients with active infection systemically or at the site of knee 5) Patients joining in another clinical study

Design outcomes

Primary

Measure	Time frame
Clinical outcom at 3, 6, and 12 months after surgery (Lysholm score)	—

Secondary

Measure	Time frame
Computer tomography at 6 and 12 months after surgery	—

Countries

Japan

Contacts

Public ContactTomoyuki Matsumoto

Kobe University Graduate School of Medicine Orthopaedic Surgery

matsun@m4.dion.ne.jp078-382-5985

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026